Daily Stock List
Acadian Mining Corp. (ADA.TO)
Today we are highlighting Acadian Mining Corp. (ADA.TO), here at the QualityStocks Daily Newsletter.
Acadian Mining Corp. has several gold projects located in Atlantic Canada. The Company also owns barite properties on Cape Breton Island, Nova Scotia. Acadian's primary focus centers on the exploration and development of their two core gold deposits. These deposits are the Fifteen Mile Stream and Beaver Dam Projects. Acadian Mining has their headquarters in Halifax, Nova Scotia. The Company’s shares list on the Toronto Stock Exchange and on the OTCQX International under the trading symbol ADAIF.
The majority of Acadian Mining's resources will be directed toward the Fifteen Mile Stream and Beaver Dam Projects for the foreseeable future. The Company owns an extensive portfolio of non-core assets, in addition to their core assets. Both of Acadian’s potential open-pit gold properties host National Instrument 43-101 compliant resources, and form the core holdings of an extensive suite of Scotia Goldfields projects. The Scotia Goldfield's continue to gain prominence with recognition of their potential to host large, bulk tonnage-open pit gold deposits along the Fifteen Mile Stream trend, as well as high grade underground deposits with substantial depth potential.
Earlier this month, Acadian Mining announced that they filed on SEDAR a Technical Report on an Updated Mineral Resource Estimate for the Company's wholly-owned Fifteen Mile Stream Property dated August 29, 2012. The updated NI 43-101 compliant mineral resource estimate for the Main Zone (Egerton-MacLean Zone) of the Fifteen Mile Stream deposit is 308,000 ounces of gold in the inferred category with an average grade of 1.6 g/t Au at a cut-off of 0.7 g/t Au.
This week, Acadian Mining announced that they entered into an agreement for the sale of two of their non-core assets. Acadian agreed to sell their Tangier and Forest Hill properties to a private company that plans to develop the gold properties. Acadian will receive $700,000 for the two non-core assets.
The monetization of some of their non-core assets will provide Acadian with funds that can be directed toward development of their core projects. It will also allow Acadian to build an attractive royalty portfolio and relieve the Company of some of their property holding costs.
Acadian Mining Corp. (ADA.TO), closed today at $0.08, up 14.29%, on 154,600 volume. The stock's 52-week low/high is $0.05/$0.29.
Orckit Communications Ltd. (ORCT)
SmarTrend Newsletters reported recently on Orckit Communications Ltd. (ORCT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Listed on the OTC Bulletin Board, Orckit Communications Ltd. engages in the development, marketing, and sale of telecommunication transport equipment. The Company facilitates telecommunication providers' delivery of broadband residential, business, and mobile services over wireline or wireless networks. They facilitate this with their Orckit-Corrigent portfolio of products. Founded in 1990, and going public in 1996, Orckit Communications has their headquarters in Tel-Aviv, Israel.
The Company is active in Asia and Pacific (APAC), Western and Eastern Europe, and the United States. They provide multiprotocol label switching (MPLS) and MPLS-TP packet transport network switches, as well as legacy services over packet networks with a variety of transport features. Orckit markets their products to telecommunication companies directly and indirectly by way of original equipment manufacturers (OEMs), strategic alliances, and agency and distribution arrangements around the world. Orckit has substantial experience with Tier-1 customers located worldwide.
Orckit has their IP/MPLS and MPLS-TP based CM-4000 PTN switches and the accompanying CM-View network management system. The Company’s CM-4000 portfolio is a series of small, medium, and large capacity Packet Transport Network switches that offer any combination of Ethernet, SDH, and PDH services to facilitate migration towards a unified packet network. The basis of the products is on dual stack IP/MPLS and MPLS-TP, packet synchronization, and circuit emulation technologies. The design of them is to scale up the delivery of residential, business, and mobile backhauling services in next-generation telecom infrastructure networks.
Packet Transport Network (PTN) is the classic Carrier Ethernet gear. The Orckit-Corrigent CM-4000 portfolio is a PTN platform based on standard and interoperable Layer 2 MPLS and MPLS-TP. Transport-class and carrier-grade capabilities include high availability of equipment and service, redundancy, flexible configuration, multilayer OAM and QoS, SDH and PDH services over a synchronized packet network, as well as service oriented EMS/NMS.
As pertains to innovative technologies, Orckit Communications is an active partner in the OptiBand project. OptiBand focuses on optimizing the bandwidth of IPTV for the delivery of multiple HD streams over a single ADSL line, and therefore enabling multiple HD channels per household. The OptiBand project conducts in-depth research and development regarding the efficient distribution of video content using smart data drop algorithms within the telecommunication aggregation networks.
Orckit Communications Ltd. (ORCT), closed Friday’s session at $0.1999, up 5.21%, on 32,935 volume with 9 trades. The average volume for the last 60 days is 50,842 and the stock's 52-week low/high is $0.15/$0.301.
Tianyin Pharmaceutical Co., Inc. (TPI)
We are highlighting Tianyin Pharmaceutical Co., Inc. (TPI), here at the QualityStocks Daily Newsletter.
Tianyin Pharmaceutical Co., Inc. is a business entity that specializes in the development, manufacturing, marketing, and sales of patented biopharmaceutical, modernized traditional Chinese medicines, branded generics, and other pharmaceuticals. Currently, the Company manufactures a comprehensive portfolio of 58 products, 24 of which are listed in the highly selective national medicine reimbursement list; 7 are included in the essential drug list of China. Tianyin Pharmaceutical has their corporate headquarters in Chengdu, China.
The Company’s pipeline targets a variety of high incidence healthcare indications. Tianyin has two state-of-the-art manufacturing facilities. The Company also has an extensive nationwide sales and distribution network throughout China.
Tianyin Pharmaceutical’s products address significant medical needs in the therapeutic areas spanning internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, gastroenterology, orthopedics, dermatology, pediatrics, among others. Approximately half of their products are prescription medicines; the remaining is intended for the Over-The-Counter (OTC) sales.
This past summer, Tianyin Pharmaceutical provided a progress update on their Qionglai Facility (QLF). QLF construction met its July progress milestone and is on schedule to accomplish Phase I of the QLF project, which is the relocation of the Company’s TCM pre-extraction plant by the end of calendar year 2012. Tianyin reaffirmed the relocation budget assessment in total of $25 million for the project.
Today, Tianyin Pharmaceutical announced financial results for fiscal year 2012. Fiscal Year 2012 ended June 30, 2012 financial highlights include FY2012 revenue delivering $69.6 million compared with $95.2 million in FY2011. Operating income delivered $8.5 million, compared with $18.1 million in FY2011. Net Income was $6.4 million compared with $15.7 million in FY2011.
Highlights also include earnings per share of $0.22 per basic share, and $0.22 per diluted share, compared with $0.55 per basic share, or $0.53 per diluted share in FY2011. Cash and cash equivalents totaled $35.2 million on June 30, 2012; Operating cash flow for the fiscal year ended June 30, 2012 was $8.0 million, compared with $14.2 million for the fiscal year ended June 30, 2011.
Tianyin Pharmaceutical Co., Inc. (TPI), closed Friday’s trading session at $0.61, up 8.95%, on 257,733 volume with 443 trades. The average volume for the last 60 days is 32,772 and the stock's 52-week low/high is $0.25/$1.47.
SANUWAVE Health, Inc. (SNWV)
Titan Stocks, Gladiator Stocks, Stockpicktrading, Ox of Wallstreet, Penny Stock Alley, Free Penny Alerts, Free Investment Report, Explicit Penny Picks, InsidersLab, and PennyPic reported earlier on SANUWAVE Health, Inc. (SNWV), and we highlight the Company, here at the QualityStocks Daily Newsletter.
SANUWAVE Health, Inc. is a regenerative medicine company that lists on the OTC Bulletin Board. The Company focuses on the development and commercialization of noninvasive, biological response activating devices for the repair and regeneration of tissue, musculoskeletal, and vascular structures. SANUWAVE's portfolio of products and product candidates activate biologic signaling and angiogenic responses. This includes new vascularization and microcirculatory improvement. These responses help to restore the body's normal healing processes and regeneration. SANUWAVE Health is based in Alpharetta, Georgia.
The Company’s intention is to apply their Pulsed Acoustic Cellular Expression (PACE) technology in wound healing, orthopedic/spine, plastic/cosmetic, and cardiac conditions. Their lead product candidate for the worldwide wound care market, dermaPACE, is CE marked; it has Canadian device license approval for the treatment of the skin and subcutaneous soft tissue. In the United States, dermaPACE is currently under the Food and Drug Administration’s (FDA's) Premarket Approval (PMA) review process for the treatment of diabetic foot ulcers.
SANUWAVE Health researches, designs, manufactures, markets, and services their products globally. The Company believes they have demonstrated that their technology is safe and effective in stimulating healing in chronic conditions of the foot (plantar fasciitis) and the elbow (lateral epicondylitis) through their U.S. Class III PMA approved Ossatron® device, as well as stimulating bone and chronic tendonitis regeneration in the musculoskeletal environment through the utilization of their Ossatron, Evotron®, and orthoPACE® devices in Europe.
This past June, SANUWAVE Health reported the publication of peer-reviewed, preclinical osteoarthritis research that demonstrates the ability of the Company’s Extracorporeal Shock Wave Technology (ESWT) to prevent the onset of osteoarthritis after a single treatment session that showed beneficial effects in as early as two weeks and continuing for at least three months. The publication, entitled “Extracorporeal Shockwave Therapy Shows Time-Dependent Chondroprotective Effects in Osteoarthritis of the Knee in Rats,” by Wang, C. J. et al., appeared in the online edition of the Journal of Surgical Research as an ePublication ahead of print.
Last month, SANUWAVE Health reported financial results for the three and six months ended June 30, 2012. Financial highlights for the three months ended June 30, 2012 include (all comparisons are with the three months ended June 30, 2011): Revenues increasing by $46,608, or 28 percent, to $210,357 through increased sales through the Company's European distributors. Net loss for the quarter decreased by $2,147,581, or 60 percent, to $1,424,626 from $3,572,207.
Revenues for the six months ended June 30, 2012 were $448,897, compared to $415,502 for the same period in 2011, an increase of $33,395, or 8 percent. The net loss for the six months ended June 30, 2012 was $3,259,941, or ($0.16) per share, compared with a net loss of $5,755,533, or ($0.31) per share, for the same period in 2011, a reduction of $2,495,592, or 43 percent.
SANUWAVE Health, Inc. (SNWV), closed Friday’s trading at $0.295, up 20.41%, on 1,800 volume with 1 trade. The average volume for the last 60 days is 5,341 and the stock's 52-week low/high is $0.15/$3.00.
Radio One, Inc. (ROIA)
SmarTrend Newsletters and SmallCapVoice reported earlier on Radio One, Inc. (ROIA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Radio One, Inc. is an urban-oriented; multi-media enterprise that primarily targets African-American and urban consumers. The Company’s core business is their radio broadcasting franchise that is the largest radio broadcasting operation that primarily targets African-American and urban listeners. Founded in 1980, Radio One has their headquarters in Lanham, Maryland. The Company lists on the NASDAQ Capital Market.
Currently, Radio One owns and/or operates 53 broadcast stations located in 15 urban markets in the U.S. The Company has diversified their overall media platform by making acquisitions and investments in other complementary media properties.
Their other media interests include their approximately 51 percent controlling ownership interest in TV One, LLC, an African-American targeted cable television network; their 53.5 percent ownership interest in Reach Media, Inc., which operates the Tom Joyner Morning Show; and their ownership of Interactive One, LLC , an online platform serving the African-American community through social content, news, information, and entertainment. Interactive One operates several branded sites, including NewsOne, TheUrbanDaily and HelloBeautiful. Radio One also owns Community Connect, LLC, an online social networking company, which operates a number of branded websites, including BlackPlanet, MiGente, and Asian Avenue.
Radio One primarily garners revenue from the sale of advertising time and program sponsorships to local and national advertisers on their radio stations. During the three months ended March 31, 2012, approximately 51.9 percent of their net revenue came from the sale of advertising in their core radio business, excluding Reach Media. Of Radio One’s total net revenue, approximately 38.4 percent of net revenue came from local advertising and approximately 31.5 percent came from national advertising, including network advertising. In comparison, during the three months ended March 31, 2011, approximately 56.1 percent of their net revenue came from local advertising and approximately 29.1 percent, came from national advertising, including network advertising.
National advertising also includes advertising revenue generated from the Company’s Internet segment. The balance of net revenue from their radio franchise came from tower rental income, ticket sales, as well as revenue related to the Company’s sponsored events, management fees, and other revenue. The change in revenue mix is due to the consolidation of TV One.
TV One generates Radio One’s cable television revenue, and derives their revenue mainly from advertising and affiliate revenue. Advertising revenue comes from the sale of television air time to advertisers.
Radio One, Inc. (ROIA), closed Friday’s trading session at $0.81, even for the day, on 600 volume with 2 trades. The average volume for the last 60 days is 1,353 and the stock's 52-week low/high is $0.711/$1.59.
TechPrecision Corp. (TPCS)
SmallCapVoice reported previously on TechPrecision Corp. (TPCS), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
TechPrecision Corp., by way of their wholly owned subsidiaries, Ranor, Inc., and Wuxi Critical Mechanical Components Co., Ltd., is an industry leading, global manufacturer of precision, large-scale fabricated and machined metal components and systems. The Company’s mission is to be the leading end-to-end worldwide service provider to their markets by furnishing custom, fully integrated "turn-key" solutions for complete products that require custom fabrication, precision machining, assembly, integration, inspection, non-destructive evaluation, and testing. Founded in 1956, TechPrecision has their corporate headquarters in Center Valley, Pennsylvania. The Company’s shares trade on the OTC Bulletin Board.
TechPrecision works with customers to manufacture products in accordance with the customers drawings and specifications. In addition, the Company provides manufacturing engineering services to assist customers in optimizing their engineering designs for manufacturing efficiency. TechPrecision’s products are used in a variety of markets. These include renewable energy (solar and wind), medical, nuclear, defense, industrial, and aerospace. The Company’s Ranor subsidiary was founded in 1956. Ranor specializes in large-scale, precision component fabrication for the Cleantech, energy, medical, aerospace, and defense sectors. Ranor has several ASME certifications, including an N-Stamp certification for nuclear components.
The design of TechPrecision’s Wuxi Critical Mechanical Components (CMC) subsidiary was to meet the growing global demand for an experienced, knowledgeable machining and distribution center in Asia, providing large-scale component fabrication solutions for the region's solar and wind power challenges. Founded in 2010, CMC employs one of the largest forges in the industry. CMC is positioned to provide companies with quality, durable, and efficient current and next-generation components that address their industry's specific needs.
Earlier this month, TechPrecision announced that their Ranor Division received multiple orders valued at more than $1.5 million to produce product assemblies for Proton Beam cancer treatment equipment using "synchrocyclotron" technology that was recently cleared by the Food and Drug Administration (FDA). The majority of these new orders will ship in TechPrecision's fiscal year 2013, which ends March 31, 2013, with one of the orders expected to ship in early fiscal year 2014.
TechPrecision Corp. (TPCS), closed Friday’s trading session at $0.94, up 5.62%, on 7,800 volume with 2 trades. The average volume for the last 60 days is 31,739 and the stock's 52-week low/high is $0.551/$1.25.
Moneta Porcupine Mines, Inc. (MPUCF)
Today we are highlighting Moneta Porcupine Mines, Inc. (MPUCF), here at the QualityStocks Daily Newsletter.
Moneta Porcupine Mines, Inc. engages in the exploration and development of mineral resources in Canada. The Company holds a 100 percent interest in 5 core gold projects strategically located along the Destor Porcupine Fault Zone in the world class Timmins Camp in Ontario. Here, there is excellent infrastructure including access roads, water, electricity, and mills. Moneta Porcupine Mines lists on the OTC Pink Current Information (MPUCF) and on the Toronto Stock Exchange (ME.TO). The Company has their headquarters in Timmins, Ontario.
The land position is one of the largest - after three gold producers - including the highly prospective Golden Highway Project which covers 12 kilometers of a volcanic/sedimentary belt along the Destor Porcupine Fault Zone and hosts an NI 43-101 indicated resource of 1.07 million ounces gold (33. 5 Mt at 1.00 g/t) plus an NI 43-101 inferred resource of 2.07 million ounces gold (47. 8 Mt at 1.35 g/t) clustered within 4 kilometers.
The main projects are the Golden Highway Camp and the Porcupine Gold Camp. The Golden Highway Camp includes Windjammer; Southwest Zone; 55 Zone; Dyment 3; Western Zone; Landing/Twin Creeks, and Last Chance. The Porcupine Gold Camp includes Nighthawk Lake; North Tisdale; Kayorum, and West Timmins/Denton Thornloe.
Yesterday, Moneta Porcupine Mines announced positive results from their metallurgical test program on their 100 percent owned Golden Highway Project, located 100km east of Timmins, Ontario. They also announced that they have started an updated NI 43-101 Mineral Resource Estimate on the Golden Highway Project that will now include three new and previously excluded gold zones. The previous Golden Highway Project NI 43-101 resource estimate totaled 3.1Moz of gold. (Press Release of December 1, 2011).
Highlights of the metallurgical test program include recoveries of up to 96.4 percent Au for the 55 Zone, Gap Zone, Windjammer Central/South/North zones and Southwest Zone. Recoveries are consistent across all zones and suggest that the mineralization can be processed by one standardized milling method. The current metallurgical leach results are consistent with historical testing completed on the Southwest Zone by Barrick Gold and Windjammer North and South by Newmont Mining.
Moneta Porcupine Mines, Inc. (MPUCF), closed Friday’s trading session at $0.2365, up 5.58%, on 31,500 volume with 7 trades. The average volume for the last 60 days is 44,540 and the stock's 52-week low/high is $0.13/$0.3925.
LodgeNet Interactive Corp. (LNET)
StreetInsider reported this month on LodgeNet Interactive Corp. (LNET), Hit and Run Candle Sticks, Wall Street Resources, SmarTrend Newsletters, The Street, OTCPicks did earlier, and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Based in Sioux Falls, South Dakota, LodgeNet Interactive Corp. is the leading provider of interactive media and connectivity services to hospitality and healthcare businesses and the consumers they serve. Their services include Mobile and Advertising Media Solutions, Interactive Television, Broadband, and nationwide technical and professional support services. LodgeNet Interactive was named by Advertising Age as one of the Leading 100 U.S. Media Companies. The Company also has offices in New York City; Atlanta, Georgia, as well as Canada and Mexico.
The Company serves approximately 1.6 million hotel rooms worldwide. This is in addition to healthcare facilities throughout the United States. LodgeNet Interactive owns and operates businesses under the industry leading brands: LodgeNet, The Hotel Networks, and LodgeNet Healthcare. LodgeNet operates in the U.S., Canada, and Mexico. Moreover, via licensee arrangements, they provide solutions in 15 other countries.
LodgeNet Interactive envisions, and designs, delivers and manages interactive experiences for their clients. Their expertise is in integrating and implementing consumer-facing media and connectivity technology with a focus on keeping the end-consumer connected, informed and entertained.
The Company’s services include Interactive HDTV (iHDTV) Solutions; Free-To-Guest (FTG) TV Solutions; Mobile Solutions, and Broadband Solutions. Their services also include Advertising Media Solutions (LIME); Professional Solutions, as well as Connectivity Solutions. LodgeNet Interactive supports their media and connectivity solutions with a North American network of experienced field service technicians.
Last week, LodgeNet Interactive announced that they completed the installation of an IP-based Envision™ interactive TV (iTV) solution at the 517-room Pechanga Resort & Casino in Temecula, California. The Pechanga installation integrates Enseo set-top box technology and supports 650 TVs. This installation is the latest achievement in LodgeNet Interactive's strategic initiative to expand their presence in the gaming market. LodgeNet currently has Envision installed in almost 9,000 gaming guest rooms in the United States. This includes The Venetian® Resort-Hotel-Casino in Las Vegas, which is LodgeNet's largest single Envision installation.
This week, LodgeNet Interactive announced that, as part of Mr. Richard L. Battista's employment as the Company’s President and CEO, LodgeNet granted Mr. Battista 550,000 shares of restricted stock; 366,667 of those shares vest fully on the first anniversary of the effective date of Mr. Battista's employment with the Company, with the remainder vesting in six monthly instalments on the last day of each month beginning on October 31, 2013.
LodgeNet Interactive Corp. (LNET), closed Friday’s session at $0.64, up 33.96%, on 2,517,619 volume with 50 trades. The average volume for the last 60 days is 207,829 and the stock's 52-week low/high is $0.2951/$4.44.
Longhai Steel, Inc. (LGHS)
The QualityStocks Daily Newsletter would like to spotlight Longhai Steel, Inc. (LGHS). Today, Longhai Steel, Inc. closed trading at $1.17, up 15.84%, on 4,300 volume with 13 trades. The stock’s average daily volume over the past 60 days is 13,497, and its 52-week low/high is $0.15/$2.26.
Longhai Steel, Inc. (LGHS) is a leading producer of high-quality steel wire in eastern China, with annual capacity of 1.5 million metric tons. Longhai's wire is manufactured into screws, nails, and wire mesh used for fencing and to reinforce concrete. Longhai recently expanded its production facility to include specialized applications such as steel wire rope, steel strand, steel belted radial tires, and steel welding rod. Longhai Steel is headquartered in Xingtai, Hebei province, the People's Republic of China.
The company's competitive advantages are its advanced production equipment and process technology, high product quality, expedited production, and close proximity to distributors and end users. Longhai Steel recently opened a second production line, which increases its overall capacity by 67% and expands its product portfolio into higher quality steel wire for specialized applications such as steel wire rope, steel strand, steel belted radial tires, and steel welding rod.
Longhai Steel's growth strategy includes capitalizing on government actions aimed at encouraging industry consolidation via the acquisition of neighboring producers at attractive valuations. The company also plans to grow organically through capacity expansion, broadening its product portfolio, improving operating efficiencies, and continued expansion of technical expertise.
China is the world's largest producer and consumer of steel and steel wires. Demand for steel products is primarily driven by spending in the construction, automotive, and infrastructure industries in China. Continued economic development in Hebei, one of the largest steel manufacturing regions in China, and neighboring provinces, and further buildout of tier 3-6 cities in China, provide tremendous medium and long term opportunities for Longhai Steel. Disclaimer
Longhai Steel, Inc. Company Blog
Longhai Steel, Inc. News:
Longhai Steel Completes Testing of New Steel Wire Facility
Longhai Steel Provides Q2 2012 Earnings Call Transcript; Gross Profit Up 34%, EPS up 32%
Longhai Steel Announces Strong Second Quarter 2012 Operating Results
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.28, up 7.69%, on 10,952 volume with 7 trades. The stock’s average daily volume over the past 60 days is 95,259, and its 52-week low/high is $0.21/$0.835.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corp to Participate in Upcoming Investor Conference
International Stem Cell Corp Granted Key Patent for Liver Disease Program
International Stem Cell Corp. Among SeeThruEquity Company Lineup for Fall 2012 Smallcap and Microcap Investor Conference
TNI BioTech, Inc. (TNIB)
The QualityStocks Daily Newsletter would like to spotlight TNI BioTech, Inc. (TNIB). Today, TNI BioTech, Inc. closed trading at $1.50, up 7.91%, on 137,435 volume with 114 trades. The stock’s average daily volume over the past 60 days is 20,459, and its 52-week low/high is $0.72/$10.01.
TNI BioTech, Inc. (TNIB) is focused on utilizing patented immunotherapy to activate and mobilize the body's immune system to combat fatal diseases. The company's products and technologies improve the treatment and diagnosis of cancer, infections such as HIV/AIDS, and autoimmune diseases. Future initiatives include treatment for multiple sclerosis, herpes viral infections, and other conditions that result in altered-immune response.
The company's product portfolio currently includes IRT-101, an active immunotherapy that works by activating a patient's immune system against infectious diseases and tumor cells; IRT-102, an adaptive immunotherapy that works by isolating and enriching a patient's own immune cells; and IRT-103, an active immunotherapy that works by activating a patient's immune system against HIV/AIDS and tumor cells.
Leveraging the advantages of today's cutting-edge treatment options, the company aims to meet the growing demand for quality healthcare with safer, more effective radiation therapy; new-targeted drug therapies; and minimally invasive surgical alternatives around the world. TNI BioTech most recently signed a letter of intent to open clinics in Africa that will provide advanced treatment for cancer, HIV/AIDS, and autoimmune diseases.
The company plans to continue clinical trials in China during 2012 and 2013, and anticipates starting trials in the United States by early 2013.The company is also in negotiations to acquire a number of other immunotherapy products, patents, and therapies. Led by a management team with decades of experience and solid business plan, TNI BioTech is poised to improve healthcare with active and adaptive forms of improved immunotherapies. Disclaimer
TNI BioTech, Inc. Company Blog
TNI BioTech, Inc. News:
TNI BioTech Signs Agreement With Government of Malawi to Open an Oncology & Infectious Disease Clinic at Queen Elizabeth Central Hospital
TNI BioTech, Inc. Signs Memorandum of Agreement to Open Pharmaceutical Plant for the Production of IRT-103 (LDN)
Dr. Ronald Herberman Joins TNI BioTech Inc. as Senior Vice President of Research and Development and Chief Medical Officer
Skinny Nutritional Corp. (SKNY)
The QualityStocks Daily Newsletter would like to spotlight Skinny Nutritional Corp. (SKNY). Today, Skinny Nutritional Corp. closed trading at $0.006, up 7.89%, on 755,700 volume with 13 trades. The stock’s average daily volume over the past 60 days is 1,556,183, and its 52-week low/high is $0.003/$0.041.
Skinny Nutritional Corp. (SKNY) has established their Skinny Water® brand as a clear alternative to other products in the enhanced water space, with the only true zero calorie, sugar, carb, sodium, and preservative-containing beverage available. Skinny Water's proprietary formulation of essential antioxidant agents, electrolytes, and the critical vitamins our bodies need in order to achieve optimal function, uses 100% natural flavors, no preservatives, no artificial colors, and only the best purified water.
The company has constructed a network of approximately 50 domestic distributors (with three more internationally), placing product on shelves approximately 15k stores across the United States. Derived from the natural flavors contained in fruits, Skinny Water represents a fortified, extremely low-impact, great-tasting array of beverages that provide a concentrated punch of the nutrients essential for a healthier lifestyle.
The company's strong emphasis on health, fitness, and community has served marketing initiatives very well. The new age beverage segment has seen increasing momentum in recent years, with just about every beverage company getting into the game, but none of them has the kind of no-nonsense product composition behind Skinny Water, something that appeals directly to the majority of the core consumer market.
Skinny Nutritional continues to build value around the Skinny Water brand, and today has numerous trademarks in the healthy beverage and snack food categories. As consumers migrate away from sugar based beverages and empty calories, Skinny Water is ideally positioned to benefit from positive market trends as management focuses on delivering exceptional value to shareholders. Disclaimer
Skinny Nutritional Corp. Blog
Skinny Nutritional Corp. News:
Skinny Nutritional Corp. to Change the Way You Think About Your Water With the Introduction of Skinny Water pH+
A&P's 275 Stores Continue Skinny Water's Mid-Atlantic Penetration
Skinny Nutritional Corp. Enters Into $15M Financing, Positions Company to Grow Skinny Brand Portfolio Nationally
Longhai Steel, a rapidly growing producer of steel wire in and for China, has experienced tremendous annual revenue growth over the last few years, from $373,660 in 2009 to over 608,038 in 2011, due in no small part to the company’s aggressive executive management team and board of directors.
• Chaojun Wang (Chairman & CEO)
Mr. Wang has served as the Longhai’s Chairman and CEO since March 2010 and as CEO of the company’s variable interest entity Xingtai Longhai Wire Rod Co., Ltd. since its inception in 2008. He has also served as Chairman of Longhai Steel Group, the company’s related party, since 1999. Mr. Wang is also a member of the local parliament and holds a Bachelor’s Degree in Enterprise Management. He is currently also serving as Longhai’s Interim CFO.
• Steven Ross (Executive VP & Director)
Mr. Ross has over 25 years of senior management experience, ranging from high growth private companies to multi-billion dollar divisions of public enterprises. He is currently Managing Director of MTN Capital Partners, a New York-based private equity firm. Prior to joining MTN, Mr. Ross was CEO of National Investment Managers from 2006 until its sale to a private equity firm in 2011. Under his leadership, the company became the largest independent retirement services company in the country, with over $11 billion in assets under administration and operations in 17 cities in the United States.
• Dr. Michael Grieves (Director)
Dr. Grieves is a world-recognized expert in product lifecycle management, engineering, manufacturing, and information systems, and lectures worldwide on those topics. He has been the Managing Member of Michael W. Grieves, LLC since 2000 and was Research Professor of Oakland University between 2008 and 2009. Dr. Grieves has written extensively in both industry and academic periodicals and has served in executive, managerial, and entrepreneurial roles for over 40 years.
• Jeff Cooke (Director)
Mr. Cooke has been a CEO at multiple early-stage companies, and has held executive positions at Hewlett Packard, Apple Computer, and NEC. Mr. Cooke is currently President and CEO at Global Digital Strategies, Inc., which offers strategic executive leadership and specializes in providing the bridge from strategy to execution, primarily for early-stage companies and those undergoing a significant change in direction.
• Joseph ‘Josh’ Howell, III (Director)
Mr. Howell is currently Senior VP of Level 3 Communications, a global telecommunications company based in Colorado. Mr. Howell is part of the core team of executives who launched the communications company, listed it on NASDAQ, and helped build the company as it expanded to more than 45 countries. Prior to Level 3, he was Senior VP of MFS Communications, an international telecommunications company which he helped take public as part of the team of executives who built the company into the largest competitive local carrier in the U.S. and Europe.
For additional information, visit the company’s website at www.LonghaiSteelInc.com
California-based International Stem Cell Corp. announced that Dr. Simon Craw, the company’s Executive Vice President of Business Development, will attend and present at the SeeThru Equity Fall Smallcap & Microcap Conference, to be held at the Cornell Club in midtown Manhattan, New York, on Tuesday, October 2, 2012.
International Stem Cell is a biotechnology company focused on therapeutic and research products. The company has developed a powerful new stem cell technology called parthenogenesis that promises to advance the field of regenerative medicine by addressing the problem of immune-rejection.
Risk of rejection for stem cell therapeutics is proportional to the degree of difference between the immune system proteins present on the donated cells and the immune system proteins present on the cells of the recipient. The human leukocyte antigen (HLA) system is the term used for antigens important for transplantation. Normally donor tissue is screened for these immune system proteins (antigens) in order to determine the degree of compatibility with the recipient.
Parthenogenetic stem cells are pluripotent human stem cells that come from unfertilized oocytes (eggs). Because of the way they are generated, parthenogenetic stem cells have a duplicate set of human leukocyte antigen (HLA) genes, which greatly reduces the possibility of the derived cells being rejected by an individual’s immune system, meaning that a single cell line can be suitable for the treatment of millions of individuals. As such, a small number of cell lines could be sufficient to provide “immune matched” cells to a significant percentage of the world’s population. ISC has already created the first parthenogenetic stem cell line that can be a source of therapeutic cells for hundreds of millions of individuals of different genders, ages, and racial backgrounds, with minimal immune rejection after transplantation.
The company also offers specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology, in addition to stem cell-based skin care products through its subsidiary Lifeline Skin Care.
For additional information on ISCO, visit the company’s website at www.InternationalStemCell.com
HII Technologies, the Houston-based oilfield services firm with over a decade in manufacturing and service for E&P power and water management, reported wrapping the milestone AES acquisition today, adding key, high-volume fracking water infrastructure to the company’s bottom line.
AES has an established presence in the industry doing high volume water transfer via a sophisticated array of no-leak mobile piping solutions, praised not only for their performance metrics in hydraulic fracturing work, but also for their ability to ensure that environmental stewardship targets are met with ease. AES has built up a sizeable network of E&P clients in the Texas and Oklahoma region, with nationally recognized customers engaged in the burgeoning hydrocarbon recovery industry.
HIIT pretty much dumped their wholly-owned valve design and production subsidiary, KMHVC (Hemiwedge Valve Corp.) back in early 2011, but has built up the kind of lensing capability needed to produce an incredibly powerful, focused beam through the acquisition of such rich oilfield service capacity as that represented by today’s announcement. AES has a good five decades of boots on the ground in the industry doing complex, customized systems for oil and gas operators, with broad proficiencies in everything from drilling water wells, to implementing ad hoc water circuits that can handle intricate high-capacity water transferring requirements.
With some 10 miles of 10-inch aluminum, leak-proof, and cam lock connection-based piping in inventory, which they install with complete ancillary instrumentation, valves, and vents, AES can do big, temporary, on-site water transfer jobs without breaking a sweat. AES has earned its reputation by working directly with client frac engineers to design custom systems, providing everything from drilling site design and preparation, to roadways, pits, and the linings for containment/disposal facilities. A fleet of distribution manifold trailers, as well as top of the line high volume Cornell pumps (175 HP Duetz turbo engines capable of 80 BPM and 325 HP John Deeres capable of 100 BPM), all with exemplary leakage-eliminating valve designs, stands ready to be deployed for clientele. AES even has the 12-foot and 20-foot road crossings needed to do safe, convenient, low-profile crossings for driveways and roads.
HIIT will look to file an 8-K on the deal with the SEC directly and will also file an amendment to its own current report that includes the audited financials for AES by Dec 11, with full faith and confidence that the deal will be accretive to EPS.
CEO of HIIT, Matt Flemming, noted the rapid turnaround on the acquisition, having filed the LOI last month and closing the deal yesterday. Flemming underscored the $4M initial revenue guidance for the coming 12 months from AES and spoke warmly to shareholders about the advantages of the turn-key water handling capabilities for sector operators. It is an extremely valid point, especially considering the spike in demand for such high volume water handling solutions, which stem out of the constantly innovative fracking work being done in domestic hydrocarbons.
President of AES, Brent Mulliniks, P.E., affirmed his colleagues sentiments about the organic growth potential of the portfolio in today’s market, noting in particular how more recent developments in multi-stage fracking and horizontal drilling have pushed the envelope for water volumes required. Mulliniks ensured investors and markets that together AES and HIIT would be redoubling their efforts to expand the water supply services portfolio available to clients, with features like flow-back water recycling technology taking developmental precedent.
For more information on HII Technologies, Inc., please visit the company’s website at: www.HIITinc.com
Pacer International announced it has been named a “Business Partner of the Year” for 2012 by Procter & Gamble (P&G), which is the highest honor P&G gives to its suppliers and agencies.
Pacer, a leading freight transportation and global logistics services provider in North America, is the first logistics company to receive this honor from P&G. The company was among eight suppliers out of P&G’s more than 75,000 global suppliers to win the award, which Pacer received due to its demonstrated partner excellence through outstanding performance, as measured by P&G’s Supplier Performance Management System (SPMS). The P&G SPMS evaluates the performance of the company’s external business partners in the areas of commercial, operational, innovation, and relationship. Through the SPMS, P&G’s business partners are provided with a strict set of performance criteria that they must meet and maintain throughout the year.
The receipt of this distinguished award from P&G validates Pacer’s commitment to offering best-in-class customer service, as well as the company’s collaborative approach in providing innovative transportation solutions to P&G and its other customers.
The P&G organization is focused on its top business priorities, which include its external business partners, like Pacer, who help P&G innovate, more efficiently operate, and succeed in the marketplace.
Pacer International is a leading asset-light freight transportation and logistics services provider in North America. The company offers a wide range of services to promote the movement of freight from origin to destination through intermodal and logistics operating segments. The company’s intermodal segment provides container capacity, integrated local transportation services, and door-to-door intermodal shipment management. Pacer’s logistics segment offers truck brokerage, warehousing and distribution, international freight forwarding, and supply-chain management services.
For more information, visit the company’s Web site at www.pacer.com
Today's Top 3
The QualityStocks Public Company Sponsor News